Trastuzumab Recruiting Phase 3 Trials for Metastatic Breast Cancer (MBC) Treatment

Indications	Status	Purpose	Phase
DBCOND0032947 (Metastatic Breast Cancer (MBC))	Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT03262935	SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer	Eribulin (DB08871) Trastuzumab (DB00072) Capecitabine (DB01101) Vinorelbine (DB00361) Lapatinib (DB01259)
NCT02344472	Detect V / CHEVENDO (Chemo vs. Endo)	Trastuzumab (DB00072) Pertuzumab (DB06366) Letrozole (DB01006) Exemestane (DB00990) Fulvestrant (DB00947) Anastrozole (DB01217) Paclitaxel (DB01229) Capecitabine (DB01101) Docetaxel (DB01248) Vinorelbine (DB00361) Tamoxifen (DB00675)